在创伤中查甲基胺和胺的使用:一个公共卫生机会
Jordan M Rook1,2, Catherine Juillard1, Danielle Newton1
1Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, United States.
Health affairs scholar
|February 16, 2026
概括
在受伤患者中,甲基胺 (meth/amphetamine) 的使用很常见,在2017年至2022年期间,阳性率从9%增加到12%. 查创伤患者是否患有甲基/胺使用障碍可以帮助预防重伤.
科学领域:
- 创伤护理的护理人员.
- 药物成 药物成 药物
- 公共卫生 公共卫生
背景情况:
- 甲基胺 (meth/amphetamine) 的使用与无意伤害和暴力有关.
- 在美国创伤中心,对甲基/胺使用的查并不是标准的做法.
研究的目的:
- 为了确定成年创伤患者中甲基/胺阳性的患病率.
- 调查甲基/胺使用与临床结果之间的关联.
主要方法:
- 美国外科医生学院创伤质量计划数据集的分析.
- 包括来自美国873家创伤中心的数据.
- 检查了450万成年创伤患者的尿液药物查结果.
主要成果:
- 在接受查的创伤患者中,有11%的测试结果为甲基/安非他命阳性.
- 甲基/安非他胺阳性率从2017年的9%增加到2022年的12%.
- 阳性检测的患者有更严重的伤害和更长的住院时间.
结论:
- 在创伤患者中,甲基/安非他胺的使用普遍,超过了全国平均水平.
- 创伤中心为查和干预甲基/胺使用障碍提供了机会.
- 解决甲基/胺使用问题可以防止重伤,改善患者和社区的健康.
相关概念视频
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.